Kermanshah University of Medical Sciences, Kermanshah, Iran
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
How to Cite:
O. Modified Intermediate-Dose Cytarabine Combined with Daunorubicin Induction and Re-Induction Protocol Use in Patients with Acute Myeloid Leukemia,
Int J Cancer Manag.
International Journal of Cancer Management:
10 (4); e7000